Skip to main content


Hepatology International

Hepatology International OnlineFirst articles

01.08.2020 | Original Article

Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib

Lymphocyte to monocyte ratio (LMR) is a simple and straightforward parameter reflecting the state of immune homeostasis. In cancer, lymphocytes represent the ability of the host to fight against the tumor, whereas monocytes protect tumor cells by …

30.07.2020 | COVID-19 | Original Article Zur Zeit gratis

Effect of COVID-19 on patients with compensated chronic liver diseases

With the rapidly expanding coronavirus disease 2019 (COVID-19) pandemic, liver injury has been increasingly recognized as part of the clinical picture. Indeed, hepatitis with elevation of serum alanine transaminases (ALT) has been reported to …

28.07.2020 | COVID-19 | Letter to the Editor Zur Zeit gratis

Liver injury in remdesivir-treated COVID-19 patients

28.07.2020 | COVID-19 | Review Article Zur Zeit gratis

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Abnormal liver enzymes are seen in 20% of hospitalized patients with COVID-19. The etiology of elevated liver enzymes is thought to be multifactorial including medications and underlying liver disease. The true prevalence and clinical significance …

24.07.2020 | COVID-19 | Review Article Zur Zeit gratis

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Until May 6, 2020, coronavirus disease 2019 (COVID-19) has posed a serious threat to global public health with a total of 3,272,202 confirmed cases and 230,104 deaths documented in 212 countries [ 1 ]. Its pathogen is named the severe acute …

Aktuelle Ausgaben

Über diese Zeitschrift

Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences.

Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports..

Hepatology International requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.

To visit our ethics statements please visit the following links:

Conflict of Interest and Ethical Standards:

Informed Consent:

Statement of Human and Animal Rights:

Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL).

Now indexed by ISI

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin